Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Posted by Lindsey Winhoffer on Jan 15th, 2026

Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling 13,401 shares, an increase of 336.1% from the December 15th total of 3,073 shares. Based on an average daily volume of 116,065 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 116,065 shares, the days-to-cover ratio is presently 0.1 days.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. The Goldman Sachs Group lowered shares of Straumann from a “strong-buy” rating to a “neutral” rating in a report on Monday, October 13th. Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. UBS Group raised Straumann from a “sell” rating to a “neutral” rating in a research note on Tuesday, November 4th. Finally, Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Straumann currently has a consensus rating of “Hold”.

Check Out Our Latest Stock Analysis on SAUHY

Straumann Price Performance

Straumann stock opened at $12.48 on Thursday. The company’s 50 day moving average price is $11.96 and its two-hundred day moving average price is $11.98. Straumann has a 52 week low of $10.30 and a 52 week high of $15.07.

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.